Novo Holdings A/S has bought stock on 22 days since Jun 2016
10% owner at Avalyn Pharma Inc., and 30 other companies
SEC CIK 0001388325 · Filings on SEC.gov ↗
Novo Holdings A/S's record
3 months after each buy, from the first price a copier could get.
8 buys since 2016 with 3 months of prices.
Companies
- AVLN Avalyn Pharma Inc.10% owner
- MPLT MapLight Therapeutics, Inc.10% owner
- IOBT Io Biotech, Inc.10% owner
- SPRB Spruce Biosciences, Inc.10% owner
- MGX Metagenomi Therapeutics, Inc.10% owner
- CYT Cyteir Therapeutics, Inc.10% owner
- IRON Disc Medicine, Inc.10% owner
- RPHM Reneo Pharmaceuticals, Inc.10% owner
- EWTX Edgewise Therapeutics, Inc.10% owner
- BOLT Bolt Biotherapeutics, Inc.10% owner
- ACLX Arcellx Inc10% owner
- UTRS Minerva Surgical, Inc.10% owner
- INGN Inogen, Inc.10% owner
- GRTX Galera Therapeutics Inc10% owner
- INZY Inozyme Pharma, Inc.10% owner
- GLTO Galecto, Inc.10% owner
- HRMY Harmony Biosciences Holdings, Inc.10% owner
- CMPI Checkmate Pharmaceuticals, Inc.10% owner
- CRVS Corvus Pharmaceuticals, Inc.10% owner
- MIST Milestone Pharmaceuticals Inc.10% owner
- MORF Morphic Holding, Inc.10% owner
- ETTX Entasis Therapeutics Holdings Inc.10% owner
- KALV KalVista Pharmaceuticals, Inc.10% owner
- HTGM Htg Molecular Diagnostics, Inc10% owner
- ANAB AnaptysBio, Inc.10% owner
- APEN Apollo Endosurgery, Inc.10% owner
- RETA Reata Pharmaceuticals Inc10% owner
- OPHT Ophthotech Corp.10% owner
- RARX Ra Pharmaceuticals, Inc.10% owner
- CLCD Colucid Pharmaceuticals, Inc.10% owner
- TBRA Tobira Therapeutics, Inc.10% owner
Every filing
65 filings since Mar 2016, newest first
Anaptysbio Inc
10% owner
Apollo Endosurgery, Inc.
10% owner
Reata Pharmaceuticals Inc
10% owner
Reata Pharmaceuticals Inc
10% owner
Reata Pharmaceuticals Inc
10% owner
Ophthotech Corp.
10% owner
Ra Pharmaceuticals, Inc.
10% owner
Colucid Pharmaceuticals, Inc.
10% owner
Tobira Therapeutics, Inc.
10% owner
Tobira Therapeutics, Inc.
10% owner
Tobira Therapeutics, Inc.
10% owner
Tobira Therapeutics, Inc.
10% owner
Reata Pharmaceuticals Inc
10% owner
Ophthotech Corp.
10% owner
Tobira Therapeutics, Inc.
10% owner
About Novo Holdings A/S
Novo A/S, also referred to as Novo Holdings A/S, is a Danish investment firm and a major beneficial owner (BO) in various biotechnology companies, including a recent 10% stake in Maplight Therapeutics, Inc. (MPLT) as reported in Form 4 insider trading filings.( As a corporate insider, it has engaged in trading activities related to MPLT, reflecting its strategy of investing in life sciences and healthcare sectors.(
Novo Holdings A/S originates from the Novo Nordisk Foundation and manages significant assets, focusing on biotechnology, pharmaceuticals, and innovation to support long-term value creation in healthcare.( Its operations involve equity investments, venture capital, and ownership stakes in companies advancing treatments for chronic diseases like diabetes and obesity, leveraging deep roots in Denmark's pharmaceutical heritage through its association with Novo Nordisk A/S.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.